Journal of Pharmacology and Experimental Therapeutics: 258 (2)

August 01, 1991; Volume 258,Issue 2

You have access
Energetic aspects of the regulation of Ca++ sensitivity of permeabilized rabbit mesenteric artery: possible involvement of a second Ca++ regulatory system in smooth muscle contraction.
J Nishimura and C van Breemen

Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 397-402;
You have access
Correlation of the amnestic effects of nicotinic antagonists with inhibition of regional brain acetylcholine synthesis in rats.
K Elrod and J J Buccafusco

Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 403-409;
You have access
Selective effects of acute and chronic ethanol exposure on neuropeptide and guanine nucleotide stimulated phospholipase C activity in intact N1E-115 neuroblastoma.
T L Smith

Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 410-415;
You have access
The antifibrillatory actions of UK-68,798, a class III antiarrhythmic agent.
S C Black, L G Chi, D X Mu and B R Lucchesi

Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 416-423;
You have access
[3H]domperidone binding to the kidney inner medullary collecting duct dopamine-2K (DA2K) receptor.
T Huo and D P Healy

Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 424-428;
You have access
Action of adenosine in estrogen-primed nonpregnant guinea pig myometrium: characterization of the smooth muscle receptor and coupling to phosphoinositide metabolism.
W P Schiemann, K O Doggwiler and I L Buxton

Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 429-437;
You have access
Relative efficacy of spinal alpha-2 agonists, dexmedetomidine, clonidine and ST-91, determined in vivo by using N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline, an irreversible antagonist.
Y Takano and T L Yaksh

Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 438-446;
You have access
Antagonistic effect of amiloride on alpha-2 adrenoceptor-mediated pigment aggregation: pharmacological heterogeneity between B-HT 920 and noradrenaline.
S P Svensson, L G Mårtensson, N Grundström, R G Andersson, E J Cragoe and J O Karlsson

Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 447-451;
You have access
Contribution of K+ channels to arachidonic acid-induced endothelium-dependent vasodilation in rat isolated perfused mesenteric arteries.
A S Adeagbo and K U Malik

Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 452-458;
You have access
Transport mechanism of a new behaviorally highly potent adrenocorticotropic hormone (ACTH) analog, ebiratide, through the blood-brain barrier.
T Shimura, S Tabata, T Ohnishi, T Terasaki and A Tsuji

Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 459-465;
You have access
L-dihydroxyphenylalanine methyl ester is a potent competitive antagonist of the L-dihydroxyphenylalanine-induced facilitation of the evoked release of endogenous norepinephrine from rat hypothalamic slices.
Y Goshima, S Nakamura and Y Misu

Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 466-471;
You have access
Alpha-2 adrenoreceptor-mediated decrease in gamma-aminobutyric acid outflow in cortical slices and synaptosomes during morphine tolerance.
L Beani, C Bianchi, L Ferraro, M Morari, M Simonato, G Spalluto and S Tanganelli

Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 472-476;
You have access
Cocaine pharmacokinetics in the pregnant guinea pig.
J A Sandberg and G D Olsen

Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 477-482;
You have access
Kindling as a model of drug-resistant partial epilepsy: selection of phenytoin-resistant and nonresistant rats.
W Löscher and C Rundfeldt

Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 483-489;
You have access
Adenosine A1 and A2 receptors mediate presynaptic inhibition and postsynaptic excitation in guinea pig submucosal neurons.
C Barajas-Lopez, A Surprenant and R A North

Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 490-495;
You have access
Age-related differences in the effects of some muscarinic agents on acetylcholine release from rat neostriatal slices.
H J Lee, N V Cozzi and M H Weiler

Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 496-501;
You have access
Mirfentanil: pharmacological profile of a novel fentanyl derivative with opioid and nonopioid effects.
C P France, G Winger, F Medzihradsky, M R Seggel, K C Rice and J H Woods

Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 502-510;
You have access
Analgesic and hyperthermic effects of intravenously administered morphine in the rat are related to its serum levels.
H N Bhargava, V M Villar, A Gulati and G Chari

Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 511-516;
You have access
Spinal and supraspinal components of cannabinoid-induced antinociception.
A H Lichtman and B R Martin

Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 517-523;
You have access
Endothelin and calcium signaling in NG108-15 neuroblastoma x glioma cells.
J Chan and D A Greenberg

Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 524-530;
You have access
Competition of leukotrienes and ICI-198,615 for [3H]LTD4 binding sites in guinea pig lung membranes suggests the involvement of two LTD4 receptor subtypes.
J T Shirley and J B Cheng

Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 531-536;
You have access
Mechanisms for the uptake of cationic drugs by the liver: a study with tributylmethylammonium (TBuMA).
H Steen, R Oosting and D K Meijer

Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 537-543;
You have access
Characteristics of dose-dependent antagonism by beta-funaltrexamine of the antinociceptive effects of intrathecal mu agonists.
E Mjanger and T L Yaksh

Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 544-550;
You have access
Naltrexone modulation of nicotinic acetylcholine receptor activity.
A C Le Dain, B W Madsen and R O Edeson

Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 551-558;
You have access
Interaction between methotrexate, "rescue" agents and cell proliferation as modulators of homocysteine export from cells in culture.
H Refsum, B Christensen, R Djurhuus and P M Ueland

Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 559-566;
You have access
The platelet activating factor receptor antagonist, RP 59227, blocks platelet activating factor receptors mediating liberation of reactive oxygen species in guinea pig macrophages and human polymorphonuclear leukocytes.
A Floch, L Tahraoui, P Sedivy and I Cavero

Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 567-575;
You have access
Evidence for central alpha-2 adrenoceptors, not imidazoline binding sites, mediating the ethanol-attenuating properties of alpha-2 adrenoceptor antagonists.
M J Durcan, R G Lister and M Linnoila

Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 576-582;
You have access
Lack of antinociceptive cross-tolerance between [D-Pen2, D-Pen5]enkephalin and [D-Ala2]deltorphin II in mice: evidence for delta receptor subtypes.
A Mattia, T Vanderah, H I Mosberg and F Porreca

Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 583-587;
You have access
Caffeine and theophylline as adenosine receptor antagonists in humans.
I Biaggioni, S Paul, A Puckett and C Arzubiaga

Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 588-593;
You have access
Biotransformation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in primary cultures of mouse astrocytes.
D A Di Monte, E Y Wu, I Irwin, L E Delanney and J W Langston

Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 594-600;
You have access
Platelet-activating factor receptor blocking reduces proteinuria and improves survival in lupus autoimmune mice.
M Morigi, D Macconi, E Riccardi, P Boccardo, P Zilio, T Bertani and G Remuzzi

Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 601-606;
You have access
Activation of phospholipase D by E-series prostaglandins in human erythroleukemia cells.
H Wu, J T Turner and S P Halenda

Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 607-612;
You have access
Tetanus toxin and neuronal membranes: the relationship between binding and toxicity.
N Bakry, Y Kamata, R Sorensen and L L Simpson

Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 613-619;
You have access
Lipolytic activity of progesterone and synthetic progestins on rat parametrial adipocytes in vitro.
V Dorai, M C Hazard, J Paris and R Delansorne

Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 620-625;
You have access
Pharmacological characterization of the discriminative-stimulus effects of GBR 12909.
K F Melia and R D Spealman

Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 626-632;
You have access
Neuropeptide Y acts at an atypical receptor to evoke cardiovascular depression and to inhibit glutamate responsiveness in the brainstem.
L Grundemar, C Wahlestedt and D J Reis

Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 633-638;
You have access
Inhibitory effects of substance P and carbachol on the saturable sodium-dependent uptake process of myo-inositol in rat parotid gland.
Y Torrens, M Dietl, J C Beaujouan and J Glowinski

Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 639-646;
You have access
Purified choleragenoid does not induce migrating action potential complex activity in rabbit ileum in vivo.
C D Lind, R L Guerrant, A Kurosky and J R Mathias

Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 647-651;
You have access
Binding of the dihydropyridine calcium channel blocker (+)-[3H] isopropyl-4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-5-methoxycarbonyl-2, 6-dimethyl-3-pyridinecarboxylate (PN200-110) to RINm5F membranes and cells: characterization and functional significance.
G C Yaney, G A Stafford, J D Henstenberg, G W Sharp and G A Weiland

Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 652-662;
You have access
Baclofen and adenosine inhibit synaptic potentials mediated by gamma-aminobutyric acid and glutamate release in rat nucleus accumbens.
N Uchimura and R A North

Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 663-668;
You have access
Response of rat thoracic aortic rings to thromboxane mimetic U-46,619: roles of endothelium-derived relaxing factor and thromboxane A2 release.
W H Folger, D Lawson, C S Wilcox and J L Mehta

Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 669-675;
You have access
Effect of accumulation of NKY-722, a water-soluble vasoselective Ca++ antagonist, on KCl-induced contraction in isolated canine mesenteric arteries.
H Shimaji, H Shirahase, M Kanda, S Osumi and K Kurahashi

Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 676-680;
You have access
A WB 4101-sensitive alpha-1 adrenergic receptor subtype modulates repolarization in canine Purkinje fibers.
J H Lee, S F Steinberg and M R Rosen

Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 681-687;
You have access
U-78517F: a potent inhibitor of lipid peroxidation with activity in experimental brain injury and ischemia.
E D Hall, J M Braughler, P A Yonkers, S L Smith, K L Linseman, E D Means, H M Scherch, P F Von Voigtlander, R A Lahti and E J Jacobsen

Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 688-694;
You have access
Presystemic and systemic chiral inversion of R-(-)-fenoprofen in the rat.
B W Berry and F Jamali

Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 695-701;
You have access
Identification of a 17-kDa protein associated with the peripheral-type benzodiazepine receptor in vascular and other smooth muscle types.
D A Cox, P T Ellinor, T L Kirley and M A Matlib

Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 702-709;
You have access
Studies of concanavalin A in nonobese diabetic mice. I. Prevention of insulin-dependent diabetes.
R B Pearce and C M Peterson

Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 710-715;
You have access
Studies of concanavalin A in nonobese diabetic mice. II. Lymphocyte tracking and phenotype responses.
B Mukherjee, R B Pearce, B Formby and C M Peterson

Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 716-721;
You have access
Propafenone disposition and pharmacodynamics in normal and norepinephrine-induced cardiomyopathic rabbit hearts.
A M Gillis, W M Lester and R Keashly

Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 722-727;
You have access
Inhibitory influence of the mesocortical dopaminergic neurons on their target cells: electrophysiological and pharmacological characterization.
R Godbout, J Mantz, S Pirot, J Glowinski and A M Thierry

Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 728-738;
You have access
Toxicity to isolated hepatocytes caused by the intracellular calcium indicator, Quin 2.
L Carpenter-Deyo, J R Duimstra, O Hedstrom and D J Reed

Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 739-746;
You have access
Involvement of calcium and iron in Quin 2 toxicity to isolated hepatocytes.
L Carpenter-Deyo and D J Reed

Journal of Pharmacology and Experimental Therapeutics August 1991, 258 (2) 747-752;

Main menu

User menu

Search

Table of Contents

In this issue

Navigate

More Information

ASPET's Other Journals